BSEM - Company ID 0001658678
BIOSTEM TECHNOLOGIES trades as BSEM. In its fiscal 2025 annual report the company posted revenue of $47.48M, down 31.8% from the prior year and net income of -$6.58M. This page tracks BIOSTEM TECHNOLOGIES through 73 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| 424B3 | - | 2026-10-13 |
| EFFECT | - | 2026-10-09 |
| D | - | 2026-10-09 |
| Insider trade | 4 | 2026-10-09 |
| Insider trade | 4 | 2026-10-09 |
| Employee stock plan | S-8 | 2026-10-06 |
| IPO registration | S-1 | 2026-10-02 |
| Major company event | 8-K | 2026-09-30 |
The largest companies sharing BIOSTEM TECHNOLOGIES's SEC industry classification (biological products, (no diagnostic substances)).
BIOSTEM TECHNOLOGIES reported revenue of $47.48M for fiscal year 2025, a decrease of 31.8% year over year.
In its latest fiscal year BIOSTEM TECHNOLOGIES reported a net loss of $6.58M.